Cargando…
Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel
BACKGROUND: Mesenchymal stem cells are a promising cell source for chondrogenic differentiation and have been widely used in several preclinical and clinical studies. However, they are prone to an unwanted differentiation process towards hypertrophy that limits their therapeutic efficacy. Matrix met...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545577/ https://www.ncbi.nlm.nih.gov/pubmed/33036643 http://dx.doi.org/10.1186/s13287-020-01930-1 |
_version_ | 1783592056081350656 |
---|---|
author | Jahangir, Shahrbanoo Eglin, David Pötter, Naomi Khozaei Ravari, Mojtaba Stoddart, Martin J. Samadikuchaksaraei, Ali Alini, Mauro Baghaban Eslaminejad, Mohammadreza Safa, Majid |
author_facet | Jahangir, Shahrbanoo Eglin, David Pötter, Naomi Khozaei Ravari, Mojtaba Stoddart, Martin J. Samadikuchaksaraei, Ali Alini, Mauro Baghaban Eslaminejad, Mohammadreza Safa, Majid |
author_sort | Jahangir, Shahrbanoo |
collection | PubMed |
description | BACKGROUND: Mesenchymal stem cells are a promising cell source for chondrogenic differentiation and have been widely used in several preclinical and clinical studies. However, they are prone to an unwanted differentiation process towards hypertrophy that limits their therapeutic efficacy. Matrix metallopeptidase 13 (MMP-13) is a well-known factor regulated during this undesirable event. MMP-13 is a collagen degrading enzyme, which is also highly expressed in the hypertrophic zone of the growth plate and in OA cartilage. Accordingly, we investigated the effect of MMP-13 inhibition on MSC hypertrophy. METHODS: In this study, 5-bromoindole-2-carboxylic acid (BICA) was used as an inhibitory agent for MMP-13 expression. After identifying its optimal concentration, BICA was mixed into a hydrogel and the release rate was studied. To prepare the ideal hydrogel, chondroitin sulfate (CS) and platelet lysate (PL) were mixed with sodium alginate (Alg) at concentrations selected based on synergistic mechanical and rheometric properties. Then, four hydrogels were prepared by combining alginate (1.5%w/v) and/or CS (1%w/v) and/or PL (20%v/v). The chondrogenic potential and progression to hypertrophy of human bone marrow-derived mesenchymal stem cell (hBM-MSC)-loaded hydrogels were investigated under free swelling and mechanical loading conditions, in the presence and absence of BICA. RESULTS: Viability of hBM-MSCs seeded in the four hydrogels was similar. qRT-PCR revealed that BICA could successfully inhibit MMP-13 expression, which led to an inhibition of Coll X and induction of Coll-II, in both free swelling and loading conditions. The GAG deposition was higher in the group combining BICA and mechanical stimulation. CONCLUSIONS: It is concluded that BICA inhibition of MMP-13 reduces MSC hypertrophy during chondrogenesis. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-7545577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-75455772020-10-13 Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel Jahangir, Shahrbanoo Eglin, David Pötter, Naomi Khozaei Ravari, Mojtaba Stoddart, Martin J. Samadikuchaksaraei, Ali Alini, Mauro Baghaban Eslaminejad, Mohammadreza Safa, Majid Stem Cell Res Ther Research BACKGROUND: Mesenchymal stem cells are a promising cell source for chondrogenic differentiation and have been widely used in several preclinical and clinical studies. However, they are prone to an unwanted differentiation process towards hypertrophy that limits their therapeutic efficacy. Matrix metallopeptidase 13 (MMP-13) is a well-known factor regulated during this undesirable event. MMP-13 is a collagen degrading enzyme, which is also highly expressed in the hypertrophic zone of the growth plate and in OA cartilage. Accordingly, we investigated the effect of MMP-13 inhibition on MSC hypertrophy. METHODS: In this study, 5-bromoindole-2-carboxylic acid (BICA) was used as an inhibitory agent for MMP-13 expression. After identifying its optimal concentration, BICA was mixed into a hydrogel and the release rate was studied. To prepare the ideal hydrogel, chondroitin sulfate (CS) and platelet lysate (PL) were mixed with sodium alginate (Alg) at concentrations selected based on synergistic mechanical and rheometric properties. Then, four hydrogels were prepared by combining alginate (1.5%w/v) and/or CS (1%w/v) and/or PL (20%v/v). The chondrogenic potential and progression to hypertrophy of human bone marrow-derived mesenchymal stem cell (hBM-MSC)-loaded hydrogels were investigated under free swelling and mechanical loading conditions, in the presence and absence of BICA. RESULTS: Viability of hBM-MSCs seeded in the four hydrogels was similar. qRT-PCR revealed that BICA could successfully inhibit MMP-13 expression, which led to an inhibition of Coll X and induction of Coll-II, in both free swelling and loading conditions. The GAG deposition was higher in the group combining BICA and mechanical stimulation. CONCLUSIONS: It is concluded that BICA inhibition of MMP-13 reduces MSC hypertrophy during chondrogenesis. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2020-10-09 /pmc/articles/PMC7545577/ /pubmed/33036643 http://dx.doi.org/10.1186/s13287-020-01930-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Jahangir, Shahrbanoo Eglin, David Pötter, Naomi Khozaei Ravari, Mojtaba Stoddart, Martin J. Samadikuchaksaraei, Ali Alini, Mauro Baghaban Eslaminejad, Mohammadreza Safa, Majid Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel |
title | Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel |
title_full | Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel |
title_fullStr | Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel |
title_full_unstemmed | Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel |
title_short | Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel |
title_sort | inhibition of hypertrophy and improving chondrocyte differentiation by mmp-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545577/ https://www.ncbi.nlm.nih.gov/pubmed/33036643 http://dx.doi.org/10.1186/s13287-020-01930-1 |
work_keys_str_mv | AT jahangirshahrbanoo inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel AT eglindavid inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel AT potternaomi inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel AT khozaeiravarimojtaba inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel AT stoddartmartinj inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel AT samadikuchaksaraeiali inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel AT alinimauro inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel AT baghabaneslaminejadmohammadreza inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel AT safamajid inhibitionofhypertrophyandimprovingchondrocytedifferentiationbymmp13inhibitorsmallmoleculeencapsulatedinalginatechondroitinsulfateplateletlysatehydrogel |